Axcella Health Inc.   Report issue

For profit Phase 2
Founded: Cambridge MA United States (2008)

Organization Overview

First Clinical Trial
2017
NCT03267745
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Axcella Health Inc. | Axcella Health, Inc

Active Ingredients

Drugs in Phase 2 Trials (2)

amino acids (Freamine) (5 trials)

axa1665 (2 trials)

Drugs in Other Trials (1)

axa4010 (1 trial)

Indications

Overview

  • Highest Phase: Phase 2
  • # of Trials: 8
  • # of Trial APIs: 3